Maryland Code | Chapter State Finance and Procurement Article 7 Section 331

Filter View [Reset All]
Syndicate content
StanceStateBillStatusSummary/TitleLast Actionsort icon
MDSB751PassRequiring the Secretary of Health to present decisions for the allocations of money from the Opioid Restitution Fund to the Opioid Restitution Fund Advisory Council; requiring the Maryland Department of Health to post on the Department's website cert...
[Detail][Text][Discuss]
2024-05-16
Approved by the Governor - Chapter 851
MDSB1099PassRequiring the State Emergency Medical Services Board, in collaboration with the Maryland Department of Health, to develop and implement an initiative under the Public Access Automated External Defibrillator Program to require that naloxone be co-loca...
[Detail][Text][Discuss]
2024-05-16
Approved by the Governor - Chapter 764
MDHB980PassRequiring the Secretary of Health to present decisions for the allocations of money from the Opioid Restitution Fund to the Opioid Restitution Fund Advisory Council; requiring the Maryland Department of Health to post on the Department's website cert...
[Detail][Text][Discuss]
2024-05-16
Approved by the Governor - Chapter 852
MDHB1094Intro

Sine Die
Authorizing a community-based organization to establish an overdose prevention site pilot program with the approval of the Maryland Department of Health and in consultation with the local health department; requiring a program to acquire gas chromato...
[Detail][Text][Discuss]
2024-03-04
Withdrawn by Sponsor
MDHB1031Intro

Sine Die
Repealing the requirement that each local correctional facility make available at least one formulation of each FDA-approved full opioid agonist, partial opioid agonist, and long-acting opioid antagonist used for the treatment of opioid use disorders...
[Detail][Text][Discuss]
2024-02-13
To House Judiciary Committee
MDSB801Intro

Sine Die
Repealing the requirement that each local correctional facility make available at least one formulation of each FDA-approved full opioid agonist, partial opioid agonist, and long-acting opioid antagonist used for the treatment of opioid use disorders...
[Detail][Text][Discuss]
2024-02-06
To Senate Budget and Taxation Committee
Syndicate content
feedback